Wakley G K, Baum B L, Hannon K S, Turner R T
Department of Orthopedics, Loma Linda University, California.
Calcif Tissue Int. 1988 Dec;43(6):383-8. doi: 10.1007/BF02553283.
The effects of a 3-week treatment with the nonsteroidal "antiestrogen" tamoxifen were determined on cortical and trabecular bone mass of the tibiae of growing male rats that had undergone unilateral sciatic neurotomy (USN). USN resulted in decreases in cortical area (-11.3%), cross-sectional area (-8.4%), and periosteal bone formation rate (-32.6%) in cortical bone, indicating that the disuse osteopenia results in a decrease in bone formation in cortical bone. USN significantly reduced the amount of trabecular bone in our metaphyseal sampling site (-75%), markedly increasing the amount of bone surface lined by osteoclasts (+65%) without affecting the surface lined by osteoblasts. These results suggest that trabecular bone disuse osteopenia is due, at least in part, to increased bone resorption. Tamoxifen treatment significantly reduced the loss of trabecular bone, restoring resorbing surface length to the control (sham-operated) animal levels. Tamoxifen treatment of sham-operated animals increased trabecular bone area and surface by 35.7% (+/- 10.5) and 41.8% (+/- 7.8), respectively, and reduced resorbing surface by 21.5% (+/- 11.6) compared with sham-operated placebo-treated rats. Tamoxifen had no significant effect on cortical bone parameters in the sham-operated group. The results indicate that tamoxifen is able to reduce the trabecular bone loss that results from USN, but has no effect on cortical bone disuse osteopenia, or on trabecular bone formation. Moreover, tamoxifen treatment of control (intact) animals inhibited the normal levels of bone resorption occurring in these rapidly growing animals.
研究了非甾体“抗雌激素”他莫昔芬对经历单侧坐骨神经切断术(USN)的生长雄性大鼠胫骨皮质骨和小梁骨质量的3周治疗效果。USN导致皮质骨的皮质面积减少(-11.3%)、横截面积减少(-8.4%)和骨膜骨形成率降低(-32.6%),表明废用性骨质减少导致皮质骨骨形成减少。USN显著降低了我们干骺端采样部位的小梁骨量(-75%),显著增加了破骨细胞衬里的骨表面积(+65%),而不影响成骨细胞衬里的表面。这些结果表明,小梁骨废用性骨质减少至少部分是由于骨吸收增加所致。他莫昔芬治疗显著减少了小梁骨的丢失,使吸收表面长度恢复到对照(假手术)动物水平。与假手术安慰剂治疗的大鼠相比,他莫昔芬治疗假手术动物使小梁骨面积和表面分别增加了35.7%(±10.5)和41.8%(±7.8),并使吸收表面减少了21.5%(±11.6)。他莫昔芬对假手术组的皮质骨参数无显著影响。结果表明,他莫昔芬能够减少USN导致的小梁骨丢失,但对皮质骨废用性骨质减少或小梁骨形成无影响。此外,他莫昔芬治疗对照(完整)动物抑制了这些快速生长动物中正常水平的骨吸收。